Home › Myelofibrosis › Oregon › Portland
Myelofibrosis clinical trials in Portland, OR
5 studies for Myelofibrosis are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
RecruitingPhase 2
- Oregon Health and Science University, Portland
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RecruitingPhase 1/2
- Oregon Health and Science University, Portland
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RecruitingPhase 3
- Oregon Health and Science University, Portland
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RecruitingPhase 2
- Oregon Health & Science University, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Portland
Myelofibrosis trials in other cities
- Houston, TX19 studies
- New York City, NY18 studies
- Boston, MA12 studies
- Durham, NC12 studies
- Seattle, WA11 studies
- Columbus, OH11 studies
- Miami, FL10 studies
- Cleveland, OH9 studies
- Baldwin Park, CA9 studies
- Nashville, TN9 studies
- Atlanta, GA9 studies
- Tampa, FL9 studies
Other studies in Portland
- Non-Small Cell Lung Cancer45 studies
- Cancer (all types)35 studies
- Prostate Cancer33 studies
- Breast Cancer32 studies
- Metastatic Cancer30 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Endometrial Cancer25 studies
- Acute Myeloid Leukemia25 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.